Nasim Ali
Impact in
-
- Sarcoma Diagnosis and Treatment
-
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
Papers in
-
- Sarcoma Diagnosis and Treatment 7
- Lung Cancer Treatments and Mutations 1
- Gastric Cancer Management and Outcomes 1
-
- Chemotherapy-induced cardiotoxicity and mitigation 1
- Co-authors
- Charlotte Benson (6 shared papers)Penella J. Woll (2 shared papers)Sandra J. Strauss (3 shared papers)Michael Leahy (3 shared papers)Beatrice Seddon (2 shared papers)Maria Marples (2 shared papers)Fiona Cowie (1 shared paper)Christian Rothermundt (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)JAMA Oncology (1 paper)European Journal of Surgical Oncology (1 paper)The Lancet Oncology (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United KingdomFranceBelgium
In The Last Decade
Nasim Ali
10 papers receiving 414 citations
Nasim Ali's Hit Papers
Peers
Comparison fields: 5 of 42
- Pulmonary and Respiratory Medicine 280
- Oncology 191
- Obstetrics and Gynecology 41
- Cardiology and Cardiovascular Medicine 78
- Gastroenterology 18
Countries citing papers authored by Nasim Ali
This map shows the geographic impact of Nasim Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasim Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasim Ali more than expected).
Fields of papers citing papers by Nasim Ali
This network shows the impact of papers produced by Nasim Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasim Ali. The network helps show where Nasim Ali may publish in the future.
Co-authors
The 25 scholars most cited alongside Nasim Ali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial Hit paper breakdown → | 2017 | 345 |
| 2 | 2011 | 21 | |
| 3 | 2018 | 19 | |
| 4 | 2019 | 10 | |
| 5 | 2023 | 6 | |
| 6 | 2020 | 4 | |
| 7 | 2021 | 3 | |
| 8 | 2013 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 2 |
About Nasim Ali
Nasim Ali is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Oncology, Surgery and Gastroenterology, having authored 10 papers that have together received 416 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (1 paper), Lung Cancer Treatments and Mutations (1 paper), Gastrointestinal Tumor Research and Treatment (1 paper), Management of metastatic bone disease (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (280 citations), Oncology (191 citations), Obstetrics and Gynecology (41 citations), Cardiology and Cardiovascular Medicine (78 citations) and Gastroenterology (18 citations). Nasim Ali has collaborated with scholars based in United Kingdom, France and Belgium. Frequent co-authors include Charlotte Benson, Penella J. Woll, Sandra J. Strauss, Michael Leahy, Beatrice Seddon, Maria Marples, Fiona Cowie, Christian Rothermundt, Sharon Forsyth and Sandy Beare. Their work appears in journals such as Journal of Clinical Oncology, JAMA Oncology, European Journal of Surgical Oncology, The Lancet Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.